Covid-19: Experts criticise claim that remdesivir cuts death rates
Experts have criticised pharmaceutical firm Gilead Sciences after it released data suggesting that its antiviral drug remdesivir can reduce death rates for patients with covid-19. They say the…
Read Original Article: Covid-19: Experts criticise claim that remdesivir cuts death rates »
